| Literature DB >> 35491551 |
Vilas Sadekar1, Arun T Watts1, Elizabeth Moulder1, Panayiotis Souroullas1, Yvonne Hadland1, Elizabeth Barron1, Ross Muir1, Hemant K Sharma1.
Abstract
AIMS: The timing of when to remove a circular frame is crucial; early removal results in refracture or deformity, while late removal increases the patient morbidity and delay in return to work. This study was designed to assess the effectiveness of a staged reloading protocol. We report the incidence of mechanical failure following both single-stage and two stage reloading protocols and analyze the associated risk factors.Entities:
Keywords: CT scanning; Clinicians; Mechanical failure; Nonunion; Refracture; deformity; dynamization; failure; fracture sites; frame removal; hexapod; ilizarov; morbidity; nonunion; radiography; refracture; reloading; trauma
Year: 2022 PMID: 35491551 PMCID: PMC9134831 DOI: 10.1302/2633-1462.35.BJO-2021-0179.R1
Source DB: PubMed Journal: Bone Jt Open ISSN: 2633-1462
Fig. 1The protocol in standard scenarios. Stage one: the nuts are loosened at the end of each threaded rod to allow axial movement across the fracture site. Stage two: the rods are removed to allow free movement. The protocol can proceed directly to stage two in hexapod frames, with removal of the hexapod struts to allow free movement.
Fig. 2Schematic representation of our protocol. (Picture credit: Ms Savni Panandikar).
Fig. 3Flow diagram of patients who were included in the study.
Showing single-stage and two-stage groups well matched.
| Variable | Two-stage protocol | Single-stage protocol | p-value |
|---|---|---|---|
| Mean age, yrs (SD) | 46 (16) | 42 (18) | 0.133 |
|
| |||
| Male | 64 | 103 | 0.084 |
| Female | 31 | 46 | |
| Immunosuppressed | 0 | 1 | |
|
| |||
| Rickets | 0 | 3 | |
| Osteogenesis imperfecta | 1 | 1 | |
| Asthma/COPD | 3 | 10 | 0.232 |
| Steroid use | 1 | 3 | |
| Current/previous cancer history | 2 | 2 | |
| Peripheral vascular disease | 1 | 1 | |
| Cardiovascular disease | 5 | 6 | 0.651 |
| Diabetes | 6 | 16 | 0.241 |
| Smoking status | 42 | 52 | 0.183 |
Chi-squared test.
COPD, chronic obstructive pulmonary disease; SD, standard deviation.
Frame characteristics.
| Variable | Two-stage protocol | Single-stage protocol |
|---|---|---|
|
| ||
| Hexapod | 6 | 148 |
| Ilizarov | 89 | 1 |
|
| ||
| Trauma | 84 | 112 |
| Elective | 11 | 37 |
|
| ||
| Open | 18 | 41 |
| Closed | 77 | 108 |
|
| ||
| Femur | 2 | 3 |
| Tibia | 31 | 104 |
| Ankle | 39 | 27 |
| Knee | 23 | 13 |
Multivariate analysis for refracture.
| Refracture experienced | p-value | Odds ratio | 95% CI |
|---|---|---|---|
| Age, yrs | 0.006 | 1.07 | 1.02 to 1.17 |
| Sex | 0.165 | 0.33 | 0.07 to 0.58 |
| Smoker | 0.392 | 0.58 | 0.17 to 2.00 |
| Infection during treatment | 0.478 | 0.61 | 0.15 to 2.40 |
| Other comorbidities | 0.855 | 1.13 | 0.30 to 4.30 |
| Type of frame | 0.163 | 6.33 | 0.47 to 84.0 |
Multivariate analysis.